These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Inflammatory bowel diseases: controversies in the use of diagnostic procedures. Vucelic B. Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751 [Abstract] [Full Text] [Related]
8. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW. Am J Gastroenterol; 1999 Nov; 94(11):3248-53. PubMed ID: 10566724 [Abstract] [Full Text] [Related]
9. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Irvine EJ, Zhou Q, Thompson AK. Am J Gastroenterol; 1996 Aug; 91(8):1571-8. PubMed ID: 8759664 [Abstract] [Full Text] [Related]
11. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Vind I, Riis L, Jess T, Knudsen E, Pedersen N, Elkjaer M, Bak Andersen I, Wewer V, Nørregaard P, Moesgaard F, Bendtsen F, Munkholm P, DCCD study group. Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949 [Abstract] [Full Text] [Related]
12. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, Colitis Foundation of America, Bousvaros A, Antonioli DA, Colletti RB, Dubinsky MC, Glickman JN, Gold BD, Griffiths AM, Jevon GP, Higuchi LM, Hyams JS, Kirschner BS, Kugathasan S, Baldassano RN, Russo PA. J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505 [Abstract] [Full Text] [Related]
16. Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study. Lahat A, Lang A, Ben-Horin S. Digestion; 2012 May; 85(1):1-8. PubMed ID: 22095142 [Abstract] [Full Text] [Related]
17. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease. Sýkora J, Subrt I, Dìdek P, Siala K, Schwarz J, Machalová V, Varvarovská J, Pazdiora P, Pozler O, Stozický F. J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968 [Abstract] [Full Text] [Related]
18. Inflammatory bowel disease in Iran: a review of 457 cases. Aghazadeh R, Zali MR, Bahari A, Amin K, Ghahghaie F, Firouzi F. J Gastroenterol Hepatol; 2005 Nov; 20(11):1691-5. PubMed ID: 16246187 [Abstract] [Full Text] [Related]
19. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Herrlinger KR, Noftz MK, Dalhoff K, Ludwig D, Stange EF, Fellermann K. Am J Gastroenterol; 2002 Feb; 97(2):377-81. PubMed ID: 11866276 [Abstract] [Full Text] [Related]
20. Gender related differences in quality of life and affective status in patients with inflammatory bowel disease. Hauser G, Tkalcić M, Stimac D, Milić S, Sincić BM. Coll Antropol; 2011 Sep; 35 Suppl 2():203-7. PubMed ID: 22220436 [Abstract] [Full Text] [Related] Page: [Next] [New Search]